FDA Approves Autologous Umbilical Cord Blood Trial To Treat Autism.

HealthDay (10/13, Marcus) reported, "Autism researchers have been given the go-ahead by the US Food and Drug Administration to launch a small study in children with autism that evaluates whether a child's own umbilical cord blood may be an effective treatment." According to HealthDay, "thirty children with the disorder, aged two to seven, will receive injections of their own stem cells from umbilical cord blood banked by their parents after their births. All of the cord blood comes from the Cord Blood Registry, the world's largest stem cell bank." Researchers at California's Sutter Neuroscience Institute are conducting the placebo-controlled trial.

from DIA Daily

DIA Daily is a digest of the most important news selected from thousands of sources by the editors of BulletinHealthcare. The presence of content or advertising does not endorse, nor imply endorsement of, any products or services by the Drug Information Association. Neither BulletinHealthcare nor the Drug Information Association is liable for the use of or reliance on any information contained in this briefing.

View BulletinHealthcare's privacy policy.
Drug Information Association | 800 Enterprise Road, Suite 200 | Horsham, PA 19044
Copyright © 2012 by BulletinHealthcare| 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191